These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 32384593)

  • 1. Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.
    Worm N
    Nutrients; 2020 May; 12(5):. PubMed ID: 32384593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
    Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
    Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
    Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Saeed N; Nadeau B; Shannon C; Tincopa M
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31888132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of NAFLD with diet, physical activity and exercise.
    Romero-Gómez M; Zelber-Sagi S; Trenell M
    J Hepatol; 2017 Oct; 67(4):829-846. PubMed ID: 28545937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
    Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)].
    Ait Boudaoud A; Rives-Lange C; Perregaux JF; Radu A; Messager-Josipowicz D; Barsamian C; Carette C; Czernichow S
    Presse Med; 2019 Dec; 48(12):1496-1501. PubMed ID: 31757727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.
    Yki-Järvinen H
    Nutrients; 2015 Nov; 7(11):9127-38. PubMed ID: 26556368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?
    Sofi F; Casini A
    World J Gastroenterol; 2014 Jun; 20(23):7339-46. PubMed ID: 24966604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches.
    Armandi A; Schattenberg JM
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34201382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.
    Browning JD; Baker JA; Rogers T; Davis J; Satapati S; Burgess SC
    Am J Clin Nutr; 2011 May; 93(5):1048-52. PubMed ID: 21367948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
    Parker A; Kim Y
    Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients.
    Abbate M; Mascaró CM; Montemayor S; Barbería-Latasa M; Casares M; Gómez C; Angullo-Martinez E; Tejada S; Abete I; Zulet MA; Sureda A; Martínez JA; Tur JA
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33672073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.